Literature DB >> 3192642

Extraction of [99mTc]-d,l-HM-PAO across the blood-brain barrier.

A R Andersen1, H Friberg, K B Knudsen, D I Barry, O B Paulson, J F Schmidt, N A Lassen, R D Neirinckx.   

Abstract

The initial extraction (E) across the blood-brain barrier (BBB) of [99mTc]-d,l-HM-PAO after intracarotid injection was measured in 14 Wistar rats and 6 patients using the double indicator, single injection method with Na-24 as the cotracer. In both series, cerebral blood flow (CBF) was measured using the initial slope of the xenon-133 washout curve after intracarotid bolus injection. In rats, bolus size (20 or 120 microliters), bolus type (saline or 10% albumin), or CBF were changed. First-pass extraction was dependent on CBF (p less than 0.001): With a small bolus of saline and at resting CBF (0.75 ml/g/min), E was 0.81, decreasing to 0.56 at a high CBF (1.5 ml/g/min). The calculated permeability surface area product (PS) increased linearly from 1.2 to 1.5 ml/g/min when CBF increased from 0.8 to 1.5 ml/g/min (p less than 0.01). E was found to increase when the bolus volume of saline was increased from 20 to 120 microliters, while using a 120 microliters bolus containing 10% albumin resulted in a decrease in E. This suggests that HM-PAO binding to albumin is not totally and rapidly reversible during a single passage through brain capillaries and that binding to blood elements may reduce the apparent extraction across brain capillaries. In patients using a bolus of 1 ml saline, E decreased linearly with increasing CBF (r = -0.81, p less than 0.001). For a CBF of 0.59 ml/g/min and an average apparent E of 0.72, an apparent PS product of 0.76 ml/g/min was calculated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192642     DOI: 10.1038/jcbfm.1988.32

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  9 in total

Review 1.  Mathematical modelling in nuclear medicine.

Authors:  J T Kuikka; J B Bassingthwaighte; M M Henrich; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1991

2.  Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.

Authors:  Y Kuwabara; Y Ichiya; M Sasaki; Y Akashi; T Yoshida; T Fukumura; K Masuda
Journal:  Eur J Nucl Med       Date:  1996-06

3.  Validation of automated brain contour determination in normal and abnormal cerebral single-photon emission tomography.

Authors:  L R van Elmbt; A Keyeux; R Demeure
Journal:  Eur J Nucl Med       Date:  1995-06

4.  The Legacy of the TTASAAN Report - Premature Conclusions and Forgotten Promises About SPECT Neuroimaging: A Review of Policy and Practice Part II.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin; Philip F Cohen
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

5.  Lassen's equation is a good approximation of permeability-surface model: new α values for ⁹⁹mTc-HMPAO and ⁹⁹mTc-ECD.

Authors:  Masashi Kameyama
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-16       Impact factor: 6.200

Review 6.  Basal and Acetazolamide Brain Perfusion SPECT in Internal Carotid Artery Stenosis.

Authors:  Teck Huat Wong; Qaid Ahmed Shagera; Hyun Gee Ryoo; Seunggyun Ha; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-01-08

7.  Differential lung uptake of 99mTc-hexamethylpropyleneamine oxime and 99mTc-duramycin in the chronic hyperoxia rat model.

Authors:  Anne V Clough; Said H Audi; Steven T Haworth; David L Roerig
Journal:  J Nucl Med       Date:  2012-10-19       Impact factor: 10.057

8.  Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; S Tsuji; N Shuke; H Sumiya; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1993-05

9.  A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; A Yagishita; S Tsuji; K Hisada
Journal:  Eur J Nucl Med       Date:  1995-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.